Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleIs It Really Happening?
Open Access

177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?

Andreas Poschenrieder, Jasminka Taleska and Leonhard Schaetz
Journal of Nuclear Medicine September 2024, 65 (9) 1340-1342; DOI: https://doi.org/10.2967/jnumed.124.267951
Andreas Poschenrieder
1Advanced Accelerator Applications, Novartis, Geneva, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jasminka Taleska
1Advanced Accelerator Applications, Novartis, Geneva, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonhard Schaetz
2Novartis Pharma AG, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 9 1340-1342
DOI 
https://doi.org/10.2967/jnumed.124.267951
PubMed 
39117451

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication May 20, 2024
  • Accepted for publication July 17, 2024
  • Published online September 3, 2024.

Article Versions

  • previous version (August 8, 2024 - 08:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: https://jnm.snmjournals.org/page/permissions.

Author Information

Statistics from Altmetric.com

Cited By...

  • 4 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 99mTc-MIP-1404 SPECT/CT Companion Diagnostic for177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Thorsten Derlin, Liam Widjaja, Nina Natascha Harke, Christoph Czerner, Desiree Weiberg, Tobias L. Ross, Frank M. Bengel
    Journal of Nuclear Medicine 2025 66 3
  • Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer
    Christian Lis, Friedrich-Alexander Ludwig, Steffen Fischer, Martin Ullrich, Hans-Joachim Lankau, Wiebke Sihver, Daniel Gündel, Desna Joseph, Christoph Meyer, Klaus Kopka, Jens Pietzsch, Peter Brust, Alexander Hoepping
    Journal of Medicinal Chemistry 2025 68 7
  • Feasibility of177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
    Federico Zagni, Luigia Vetrone, Andrea Farolfi, Maria Vadalà, Elisa Lodi Rizzini, Arber Golemi, Lidia Strigari, Stefano Fanti
    Journal of Nuclear Medicine 2024
  • On LVR-15 radioisotope production capabilities
    Peter Krásny, Branislav Belko
    Annals of Nuclear Energy 2025 214

Article usage

Article usage: August 2024 to May 2025

AbstractFullPdf
Aug 202401620391
Sep 202401087357
Oct 20240415131
Nov 2024031562
Dec 2024019044
Jan 2025020153
Feb 2025023652
Mar 2025015053
Apr 2025027563
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (9)
Journal of Nuclear Medicine
Vol. 65, Issue 9
September 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
Andreas Poschenrieder, Jasminka Taleska, Leonhard Schaetz
Journal of Nuclear Medicine Sep 2024, 65 (9) 1340-1342; DOI: 10.2967/jnumed.124.267951

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
Andreas Poschenrieder, Jasminka Taleska, Leonhard Schaetz
Journal of Nuclear Medicine Sep 2024, 65 (9) 1340-1342; DOI: 10.2967/jnumed.124.267951
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • A 177Lu-PSMA REVOLUTION IN ONCOLOGY: THE TIPPING POINT
    • SCALING RPT TO WIDER CLINICAL PRACTICE: THE CHALLENGES
    • CONCLUSION AND FUTURE OUTLOOK
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 99mTc-MIP-1404 SPECT/CT Companion Diagnostic for 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
  • Feasibility of 177Lu-PSMA Administration as Outpatient Procedure for Prostate Cancer
  • Google Scholar

More in this TOC Section

  • Is 211At Really Happening?
  • Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?
  • SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy
Show more Is It Really Happening?

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire